CORT · Categories · Form 4
CORT - SEC Form 4 insider transactions
Corcept Therapeutics Incorporated (CORT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for CORT
- Director Wilson James N gifted 2,000 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Guyer William4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Wilson James N4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Belanoff Joseph K4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Wilson James N4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Guyer William4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Baker G Leonard Jr4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Wilson James N gifted 28,000 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Mahoney David L exercised 30,000 shares at a strike of $5.86, covered exercise/tax liability with 5,469 shares, gifted 24,531 shares and acquired 24,531 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 8,233 shares at a strike of $21.65 and sold $296,346 worth of shares (8,233 units at $35.99) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas was granted 796 shares and covered exercise/tax liability with 89 shares, increasing direct ownership by 7% to 11,230 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean was granted 908 shares and covered exercise/tax liability with 110 shares, increasing direct ownership by 10% to 8,977 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles was granted 998 shares and covered exercise/tax liability with 121 shares, increasing direct ownership by 1% to 79,503 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William was granted 996 shares, increasing direct ownership by 81% to 2,231 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Financial Officer Mokari Atabak was granted 794 shares and covered exercise/tax liability with 96 shares, increasing direct ownership by 5% to 15,257 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Officer Lyon Joseph Douglas4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Belanoff Joseph K4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Mokari Atabak4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Officer Maduck Sean4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Business Officer Robb Gary Charles4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Hunt Hazel4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- SEC Form 4 filed by Chief Development Officer Guyer William4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Wilson James N exercised 100,000 shares at a strike of $3.88, covered exercise/tax liability with 10,636 shares, gifted 89,364 shares and acquired 89,364 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean gifted 54,570 shares and acquired 54,570 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Scientific Officer Hunt Hazel exercised 150,000 shares at a strike of $3.88 and covered exercise/tax liability with 77,968 shares, increasing direct ownership by 39% to 255,437 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65 and sold $817,334 worth of shares (20,000 units at $40.87) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Baker G Leonard Jr exercised 140,000 shares at a strike of $11.49 (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65 and sold $703,656 worth of shares (20,000 units at $35.18) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Baker G Leonard Jr gifted 0 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles exercised 145,000 shares at a strike of $3.88 and covered exercise/tax liability with 80,284 shares, increasing direct ownership by 465% to 78,626 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K exercised 550,000 shares at a strike of $3.88, covered exercise/tax liability with 306,846 shares, gifted 243,154 shares and acquired 243,154 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Wilson James N acquired 400,000 shares and gifted 400,000 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65, sold $1,601,526 worth of shares (20,000 units at $80.08), was granted 448 shares, gifted 787 shares and acquired 787 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean sold $1,590,490 worth of shares (20,000 units at $79.52), was granted 410 shares, covered exercise/tax liability with 135 shares and exercised 20,000 shares at a strike of $8.27, increasing direct ownership by 3% to 8,179 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas sold $397,632 worth of shares (5,000 units at $79.53), was granted 356 shares, covered exercise/tax liability with 110 shares and exercised 5,000 shares at a strike of $13.56, increasing direct ownership by 2% to 10,523 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Financial Officer Mokari Atabak was granted 356 shares and covered exercise/tax liability with 118 shares, increasing direct ownership by 2% to 14,559 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles covered exercise/tax liability with 148 shares and was granted 448 shares, increasing direct ownership by 2% to 13,910 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K sold $3,190,796 worth of shares (40,000 units at $79.77) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Amendment: Chief Development Officer Guyer William gifted 5,287 shares, acquired 5,287 shares and sold $364,070 worth of shares (4,500 units at $80.90), closing all direct ownership in the company (SEC Form 4)4/A - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William sold $364,070 worth of shares (4,500 units at $80.90), decreasing direct ownership by 85% to 787 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65 and sold $1,507,122 worth of shares (20,000 units at $75.36) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas exercised 5,000 shares at a strike of $13.56 and sold $368,244 worth of shares (5,000 units at $73.65) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K sold $2,983,119 worth of shares (40,000 units at $74.58) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean exercised 20,000 shares at a strike of $8.27 and sold $1,479,816 worth of shares (20,000 units at $73.99) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Swisher Daniel N Jr exercised 2,200 shares at a strike of $14.08 and sold $192,588 worth of shares (2,200 units at $87.54) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65 and sold $1,798,782 worth of shares (20,000 units at $89.94) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K sold $3,403,253 worth of shares (40,000 units at $85.08) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas exercised 5,000 shares at a strike of $13.56 and sold $423,766 worth of shares (5,000 units at $84.75) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean exercised 20,000 shares at a strike of $7.95 and sold $1,701,232 worth of shares (20,000 units at $85.06) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William gifted 200 shares, decreasing direct ownership by 4% to 5,287 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Cannon Gillian gifted 7,393 shares, closing all direct ownership in the company (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Swisher Daniel N Jr exercised 2,200 shares at a strike of $14.08 and sold $159,390 worth of shares (2,200 units at $72.45) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Director Cannon Gillian exercised 11,000 shares at a strike of $22.99 and covered exercise/tax liability with 3,607 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Development Officer Guyer William exercised 20,000 shares at a strike of $21.65 and sold $1,409,848 worth of shares (20,000 units at $70.49) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Lyon Joseph Douglas was granted 400 shares, covered exercise/tax liability with 189 shares, exercised 5,000 shares at a strike of $13.56 and sold $351,247 worth of shares (5,000 units at $70.25), increasing direct ownership by 2% to 10,277 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Officer Maduck Sean exercised 20,000 shares at a strike of $5.05, sold $1,409,828 worth of shares (20,000 units at $70.49), was granted 456 shares and covered exercise/tax liability with 233 shares, increasing direct ownership by 3% to 7,904 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Executive Officer Belanoff Joseph K sold $2,821,033 worth of shares (40,000 units at $70.53) (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Financial Officer Mokari Atabak was granted 400 shares and covered exercise/tax liability with 144 shares, increasing direct ownership by 2% to 14,321 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles was granted 502 shares and covered exercise/tax liability with 256 shares, increasing direct ownership by 2% to 13,610 units (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
- Chief Business Officer Robb Gary Charles exercised 5,000 shares at a strike of $3.88, sold $165,774 worth of shares (2,326 units at $71.27) and covered exercise/tax liability with 2,674 shares (SEC Form 4)4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)